In Ae Park

785 citations
18 papers · 605 indexed · h-index 12
Topics
Breast Cancer Treatment Studies (4 papers)Cancer Risks and Factors (3 papers)Cancer Cells and Metastasis (3 papers)

In The Last Decade

In Ae Park

18 papers receiving 594 citations

Peers

In Ae Park
Comparison fields: 5 of 64
  • Oncology 319
  • Cancer Research 241
  • Molecular Biology 186
  • Pathology and Forensic Medicine 93
  • Pulmonary and Respiratory Medicine 88
Replace Morihiko Kimura with:
Morihiko Kimura Japan
Alexandre Bodmer Switzerland
Dimitrios Tryfonopoulos Greece
Yasuhiro Yanagita Japan
S. Johnston United Kingdom
A McKinna United Kingdom
Budhi Singh Yadav India
Sally Lane United Kingdom
Ling-Heng Kong China
Mareyuki Endoh Japan
In Ae Park relative to Morihiko Kimura Japan Morihiko Kimura's profile →
Citations per field
00.5×
Morihiko Kimura · 1×
Citations per year

Countries citing papers authored by In Ae Park

Since Specialization
Citations

This map shows the geographic impact of In Ae Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by In Ae Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites In Ae Park more than expected).

Fields of papers citing papers by In Ae Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by In Ae Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by In Ae Park. The network helps show where In Ae Park may publish in the future.

Co-authorship network of co-authors of In Ae Park

This figure shows the co-authorship network connecting the top 25 collaborators of In Ae Park. A scholar is included among the top collaborators of In Ae Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with In Ae Park. In Ae Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 8
2 7
3 66
4 15
5 50
6 37
7 38
8 100
9 58
10 15
11
A case of primary breast synovial sarcoma diagnosed in a young female patient
2
12 55
13 12
14 66
15 5
16 8
17 60
18 3

About In Ae Park

In Ae Park is a scholar working on Cancer Research, Oncology and Obstetrics and Gynecology, having authored 18 papers that have together received 605 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (4 papers), Cancer Risks and Factors (3 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Cancer Research (241 citations), Oncology (319 citations) and Pathology and Forensic Medicine (93 citations). In Ae Park has collaborated with scholars based in South Korea, Ethiopia and United States. Frequent co-authors include Seock‐Ah Im, Han Suk Ryu, Jee Hyun Kim, Yu Jung Kim, Dong‐Young Noh, Wonshik Han, Do‐Youn Oh, So Yeon Park, Hyo Pyo Lee and Soon Beom Kang. Their work appears in journals such as PLoS ONE, Annals of the New York Academy of Sciences and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026